Renal Neoplasms
Showing 1 - 25 of >10,000
Kidney Tumors Trial in Taoyuan (multiparametric and fat-detection magnetic resonance imaging (MRI))
Active, not recruiting
- Kidney Neoplasms
- multiparametric and fat-detection magnetic resonance imaging (MRI)
-
Taoyuan, TaiwanLi-Jen Wang
Nov 9, 2023
Cancer of Kidney, Kidney Cancer, Renal Cancer Trial in New York (124-Iodine-cG250 (124I-cG250))
Completed
- Cancer of Kidney
- +6 more
- 124-Iodine-cG250 (124I-cG250)
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Oct 3, 2022
ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)
Recruiting
- ccRCC
- +9 more
- Oral NKT2152
-
Scottsdale, Arizona
- +6 more
Oct 17, 2022
Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for
Not yet recruiting
- Kidney Tumor
- +2 more
- (no location specified)
Feb 6, 2023
Renal Cancer Trial in New York (Magnetic Resonance Imaging (MRI) Scan, Tc-99m Pentetate)
Recruiting
- Renal Cancer
- Magnetic Resonance Imaging (MRI) Scan
- Tc-99m Pentetate
-
New York, New YorkNYU Langone Health
Oct 31, 2023
Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1
Recruiting
- Carcinoma, Renal Cell
- Kidney Neoplasms
-
Yiwu, Zhejiang, ChinaThe Fourth Affiliated Hospital Zhejiang University School of Med
Mar 27, 2023
Renal Cancer Trial in Aarhus N
Enrolling by invitation
- Renal Cancer
-
Aarhus N, DenmarkUrology Department Aarhus University Hospital
Nov 21, 2023
Carcinoma, Renal Cell Carcinoma, RCC Trial in Nanjing
Recruiting
- Carcinoma
- +4 more
-
Nanjing, Jiangsu, ChinaJinling Hospital, Affiliated Hospital of Medical School, Nanjing
Jun 30, 2023
Renal Tumor Trial
Not yet recruiting
- Renal Tumor
- (no location specified)
Aug 2, 2023
PET/MR for Characterization of Renal Masses (RMs)
Recruiting
- Renal Tumor
- +2 more
- 2-Deoxy-2-[18F]fluoroglucose Positron Emission Tomography/Magnetic Resonance Imaging
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Oct 5, 2023
Renal Cancer, Tumor, Solid, Kidney Cancer Trial (HistoSonics Edison System)
Not yet recruiting
- Renal Cancer
- +4 more
- HistoSonics Edison System
- (no location specified)
Apr 18, 2023
Stereotactic Body Radiotherapy for Medically Inoperable
Recruiting
- Kidney Neoplasm
- +2 more
- SBRT
-
Terrassa, Barcelona, SpainConsorci Sanitari de Terrassa
Apr 5, 2023
Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,
Not yet recruiting
- Multiple Myeloma
- Renal Failure
- Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
-
Augusta, GeorgiaGeorgia Cancer Center-Augusta University
Nov 16, 2023
Multiomics Approach in Metastatic Clear Renal Cell Carcnoma
Recruiting
- Metastatic Clear Cell Renal Carcinoma
- CT scan
- Plasma collection
-
Milan, Mi, ItalyIstituto Tumori
Mar 13, 2023
Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))
Not yet recruiting
- Renal Cell Carcinoma
- +2 more
- Implantable Microdevice (IMD)
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 17, 2023
Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)
Recruiting
- Neoplasms
- +12 more
- Toripalimab
- +3 more
-
Nanjing, Jiangsu, ChinaJinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023
Renal Cancer, Renal Cell Carcinoma, Renal Cell Cancer Metastatic Trial
Recruiting
- Renal Cancer
- +2 more
-
Amsterdam, Noord Holland, NetherlandsAmsterdam UMC locatie VUMC
Jan 20, 2023
Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)
Not yet recruiting
- Renal Cancer
- +3 more
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Jul 24, 2023
Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial in New Brunswick (Arterial Spin
Completed
- Stage I Renal Cell Cancer
- +3 more
- Arterial Spin Labeling Magnetic Resonance Imaging
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Oct 14, 2022
Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1
Not yet recruiting
- Metastatic Clear Cell Renal Cell Carcinoma
- With Positive PSMA Expression at Tumor Sites
- 177Lu-PSMA-1 (radiopharmaceutical)
- (no location specified)
Sep 26, 2023
Kidney Cancer, Clear Cell Renal Cell Carcinoma Metastatic, Synchronous Tumor Trial in Seoul (Cytoreductive
Recruiting
- Kidney Cancer
- +2 more
- Cytoreductive nephrectomy±metastasectomy
- Human-derived materials sampling
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Mar 2, 2023
Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute
Not yet recruiting
- Advanced Clear Cell Renal Carcinoma (Ccrcc)
- Papillary Renal Cell Carcinoma (Prcc)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw
Recruiting
- Advanced Ovarian Carcinoma
- +7 more
-
Bydgoszcz, Kujawsko-pomorskie, Poland
- +2 more
Mar 7, 2023
Hereditary Leiomyomatosis Renal Cell Cancer - Study of Genetic
Recruiting
- Renal Tumor Histology
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 28, 2022